Open AccessAlternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis
Author(s) -
Jill AdlerMoore,
Jon Olson,
Richard T. Proffitt
Publication year - 2004
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkh460
Subject(s) - amphotericin b , dosing , medicine , pharmacology , systemic candidiasis , antifungal , dermatology , corpus albicans
This study was done to determine whether high dose AmBisome (4-20 mg/kg), given intermittently, could reduce the frequency of dosing needed to treat murine systemic candidiasis when compared with conventional daily treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom